Comparison of Propofol and Sevoflurane as a Primary Anesthetic for Cardiac Ablation of Atrial Fibrillation.
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02697448|
Recruitment Status : Recruiting
First Posted : March 3, 2016
Last Update Posted : March 27, 2019
|Condition or disease||Intervention/treatment||Phase|
|Atrial Fibrillation||Drug: propofol Drug: sevoflurane||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||126 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Outcomes Assessor)|
|Official Title:||Comparison of Propofol and Sevoflurane as a Primary Anesthetic for Cardiac Ablation of Atrial Fibrillation.|
|Study Start Date :||February 2016|
|Estimated Primary Completion Date :||February 2020|
|Estimated Study Completion Date :||February 2020|
Active Comparator: propofol
Participants receiving propofol as anesthetic for cardiac ablation.
Participant receives propofol as anesthetic for cardiac ablation.
Active Comparator: sevoflurane
Participants receiving sevoflurane as anesthetic for cardiac ablation.
Participant receives sevoflurane as anesthetic for cardiac ablations.
- procedure duration [ Time Frame: 1 day ]The duration of the procedure in minutes.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02697448
|Contact: Christie Aanstoos, MSN, RNfirstname.lastname@example.org|
|Contact: Ross Glenndaemail@example.com|
|United States, South Carolina|
|Medical University of South Carolina||Recruiting|
|Charleston, South Carolina, United States, 29425|
|Principal Investigator: George J Guldan, M.D.|
|Principal Investigator:||George J Guldan, M.D.||Medical University of South Carolina|